.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
US Department of Justice
Deloitte
McKinsey
Dow
Chinese Patent Office
Argus Health
Covington
Fish and Richardson

Generated: December 16, 2017

DrugPatentWatch Database Preview

Jiangsu Hengrui Med Company Profile

« Back to Dashboard

What is the competitive landscape for JIANGSU HENGRUI MED, and what generic and branded alternatives to JIANGSU HENGRUI MED drugs are available?

JIANGSU HENGRUI MED has ten approved drugs.

There is one tentative approval on JIANGSU HENGRUI MED drugs.

Summary for Jiangsu Hengrui Med

US Patents:0
Tradenames:9
Ingredients:9
NDAs:10
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jiangsu Hengrui MedCYCLOPHOSPHAMIDEcyclophosphamideINJECTABLE;INJECTION204555-003Oct 31, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui MedCYCLOPHOSPHAMIDEcyclophosphamideINJECTABLE;INJECTION204555-001Oct 31, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui MedCYCLOPHOSPHAMIDEcyclophosphamideINJECTABLE;INJECTION204555-002Oct 31, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui MedCISATRACURIUM BESYLATE PRESERVATIVE FREEcisatracurium besylate preservative freeINJECTABLE;INJECTION204960-002Sep 19, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui MedDEXMEDETOMIDINE HYDROCHLORIDEdexmedetomidine hydrochlorideINJECTABLE;INJECTION209065-001Sep 19, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui MedCISATRACURIUM BESYLATE PRESERVATIVE FREEcisatracurium besylateINJECTABLE;INJECTION204960-001Jan 27, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui MedGABAPENTINgabapentinCAPSULE;ORAL091008-002Oct 26, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui MedDOCETAXELdocetaxelINJECTABLE;INJECTION207252-001Aug 9, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui MedGABAPENTINgabapentinCAPSULE;ORAL091008-003Oct 26, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui MedOXALIPLATINoxaliplatinINJECTABLE;IV (INFUSION)203869-001Jun 18, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Baxter
Cerilliant
Cantor Fitzgerald
Novartis
Chinese Patent Office
Farmers Insurance
Deloitte
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot